InvestorsObserver is giving Heat Biologics Inc (HTBX) an Analyst Rating Rank of 79, meaning HTBX is ranked higher by analysts than 79% of stocks. The average projection by analysts for HTBX is $4.375 over the next 12 months and analyst’s classify the stock as a Strong Buy
Why are Analyst Ratings Important?
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Heat Biologics Inc Stock Today?
Heat Biologics Inc (HTBX) stock is trading at $5.81 as of 10:36 AM on Friday, Dec 11, a decline of -$0.70, or -10.78% from the previous closing price of $6.51. The stock has traded between $5.65 and $6.17 so far today. Volume today is 791,196 compared to average volume of 776,599.